Bio-Synergy brings DNA + Epigenetics kit to Mumbai

UK health science brand Bio-Synergy has brought its DNA + Epigenetics Kit to Mumbai, marketed and distributed in India by Kynora Life Sciences LLP.

Nearly one in five adults in Mumbai shows signs of metabolic syndrome, a combination of risk factors that can increase the likelihood of diabetes and heart disease. The DNA + Epigenetics Kit is designed for this important window, when people can still take meaningful steps for their long-term health.

Unlike a conventional DNA test, which reveals a fixed genetic baseline, Bio-Synergy's DNA + Epigenetics kit measures epigenetic gene methylation, showing how current lifestyle, diet, and environment alter gene expression and biological age. It analyses over 300 bodily markers and delivers a detailed report with personalised lifestyle suggestions for improvement, along with in-house researched nutraceuticals to support metabolic health. All user DNA data is kept strictly confidential.

The Mumbai event opened with an expert panel on human longevity and how advanced testing shifts preventive health from intention to action. Following the discussion, Bio-Synergy unveiled its DNA + Epigenetics Kit to its guests and members of the health and fitness community, concluding with interactive product sampling.

Dr Katherine Rahill, Ex-NASA Scientist and Chief Scientific Officer, Bio-Synergy UK, said, “At NASA, my work focused on how demanding environments change the human body over time. DNA and epigenetic testing applies the same principle we use with astronauts: measure early, understand how the body is responding, and act before small changes become lasting ones.”